Erin E. Congdon

3.5k total citations · 2 hit papers
28 papers, 2.6k citations indexed

About

Erin E. Congdon is a scholar working on Physiology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Erin E. Congdon has authored 28 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Physiology, 13 papers in Cellular and Molecular Neuroscience and 9 papers in Molecular Biology. Recurrent topics in Erin E. Congdon's work include Alzheimer's disease research and treatments (25 papers), Neuroscience and Neuropharmacology Research (13 papers) and Neuroinflammation and Neurodegeneration Mechanisms (6 papers). Erin E. Congdon is often cited by papers focused on Alzheimer's disease research and treatments (25 papers), Neuroscience and Neuropharmacology Research (13 papers) and Neuroinflammation and Neurodegeneration Mechanisms (6 papers). Erin E. Congdon collaborates with scholars based in United States, France and India. Erin E. Congdon's co-authors include Einar M. Sigurdsson, Jeff Kuret, Jiaping Gu, Karen Duff, Haishan Yin, Carmen N. Chirita, Yixiang Jiang, Hameetha Banu Rajamohamed Sait, Changyi Ji and Amber M. Tetlow and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Journal of Medicinal Chemistry.

In The Last Decade

Erin E. Congdon

27 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tau-targeting therapies for Alzheimer disease

2018 809 citations Erin E. Congdon, Einar M. Sigurdsson Nature Reviews Neurology profile →
Tau-targeting therapies for Alzheimer disease: current status and future directions

2023 168 citations Erin E. Congdon, Changyi Ji et al. Nature Reviews Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Erin E. Congdon United States	19	1.9k	969	630	625	585	28	2.6k
Sylvain Lesné United States	27	2.0k 1.1×	1.2k 1.2×	540 0.9×	848 1.4×	739 1.3×	38	3.1k
Sumihiro Maeda Japan	19	1.9k 1.0×	1.2k 1.2×	553 0.9×	814 1.3×	504 0.9×	35	2.8k
Birgit Hutter‐Paier Austria	30	1.9k 1.0×	1.1k 1.2×	628 1.0×	669 1.1×	975 1.7×	106	3.4k
Stephanie Fuller Australia	19	2.4k 1.3×	1.3k 1.4×	626 1.0×	652 1.0×	409 0.7×	29	3.3k
Wen-Lang Lin United States	8	2.6k 1.4×	1.2k 1.2×	696 1.1×	920 1.5×	696 1.2×	11	3.1k
Yifan Fu China	20	1.9k 1.0×	1.2k 1.2×	597 0.9×	726 1.2×	464 0.8×	63	2.7k
Yoshie Takaki Japan	14	2.1k 1.1×	1.1k 1.1×	649 1.0×	879 1.4×	410 0.7×	17	3.0k
Marcos J. Guerrero-Muñoz United States	19	1.8k 1.0×	959 1.0×	387 0.6×	669 1.1×	656 1.1×	28	2.3k
Janet van Eersel Australia	17	1.8k 1.0×	918 0.9×	462 0.7×	980 1.6×	534 0.9×	24	2.6k
Francisco García‐Sierra Mexico	23	2.2k 1.2×	1.4k 1.5×	544 0.9×	935 1.5×	479 0.8×	48	3.1k

Countries citing papers authored by Erin E. Congdon

Since Specialization

Citations

This map shows the geographic impact of Erin E. Congdon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erin E. Congdon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erin E. Congdon more than expected).

Fields of papers citing papers by Erin E. Congdon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erin E. Congdon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erin E. Congdon. The network helps show where Erin E. Congdon may publish in the future.

Co-authorship network of co-authors of Erin E. Congdon

This figure shows the co-authorship network connecting the top 25 collaborators of Erin E. Congdon. A scholar is included among the top collaborators of Erin E. Congdon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erin E. Congdon. Erin E. Congdon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rajamohamedsait, Hameetha B., et al.. (2025). Clearing truncated tau protein restores neuronal function and prevents microglia activation in tauopathy mice. Cell Reports. 44(10). 116291–116291.

Jiang, Yixiang, Yan Lin, Amber M. Tetlow, et al.. (2024). Single-domain antibody-based protein degrader for synucleinopathies. Molecular Neurodegeneration. 19(1). 44–44. 5 indexed citations

Jiang, Yixiang, Qian Wu, Mengyu Liu, et al.. (2023). Single-domain antibody–based noninvasive in vivo imaging of α-synuclein or tau pathology. Science Advances. 9(19). eadf3775–eadf3775. 14 indexed citations

Congdon, Erin E., Changyi Ji, Amber M. Tetlow, Yixiang Jiang, & Einar M. Sigurdsson. (2023). Tau-targeting therapies for Alzheimer disease: current status and future directions. Nature Reviews Neurology. 19(12). 715–736. 168 indexed citations breakdown →

Congdon, Erin E., Yixiang Jiang, Yan Lin, et al.. (2022). Single domain antibodies targeting pathological tau protein: Influence of four IgG subclasses on efficacy and toxicity. EBioMedicine. 84. 104249–104249. 18 indexed citations

Congdon, Erin E., Yixiang Jiang, & Einar M. Sigurdsson. (2021). Targeting tau only extracellularly is likely to be less efficacious than targeting it both intra- and extracellularly. Seminars in Cell and Developmental Biology. 126. 125–137. 25 indexed citations

Deng, Yan, et al.. (2020). Dynamics of Internalization and Intracellular Interaction of Tau Antibodies and Human Pathological Tau Protein in a Human Neuron-Like Model. Frontiers in Neurology. 11. 602292–602292. 13 indexed citations

Wu, Qian, Yang Bai, Wei Li, et al.. (2020). Increased neuronal activity in motor cortex reveals prominent calcium dyshomeostasis in tauopathy mice. Neurobiology of Disease. 147. 105165–105165. 10 indexed citations

Congdon, Erin E., Jingjing Deng, Hameetha Banu Rajamohamed Sait, et al.. (2019). Tau antibody chimerization alters its charge and binding, thereby reducing its cellular uptake and efficacy. EBioMedicine. 42. 157–173. 34 indexed citations

10.

Congdon, Erin E.. (2018). Sex Differences in Autophagy Contribute to Female Vulnerability in Alzheimer's Disease. Frontiers in Neuroscience. 12. 372–372. 57 indexed citations

11.

Congdon, Erin E. & Einar M. Sigurdsson. (2018). Tau-targeting therapies for Alzheimer disease. Nature Reviews Neurology. 14(7). 399–415. 809 indexed citations breakdown →

12.

Congdon, Erin E., Jiaping Gu, Hameetha Banu Rajamohamed Sait, & Einar M. Sigurdsson. (2013). Antibody Uptake into Neurons Occurs Primarily via Clathrin-dependent Fcγ Receptor Endocytosis and Is a Prerequisite for Acute Tau Protein Clearance. Journal of Biological Chemistry. 288(49). 35452–35465. 159 indexed citations

13.

Congdon, Erin E., et al.. (2012). Tau Isoform Composition Influences Rate and Extent of Filament Formation. Journal of Biological Chemistry. 287(24). 20711–20719. 93 indexed citations

14.

Duff, Karen, Jeff Kuret, & Erin E. Congdon. (2010). Disaggregation of Tau as a Therapeutic Approach to Tauopathies. Current Alzheimer Research. 7(3). 235–240. 15 indexed citations

15.

O’Leary, John C., Qingyou Li, Paul S. Marinec, et al.. (2010). Phenothiazine-mediated rescue of cognition in tau transgenic mice requires neuroprotection and reduced soluble tau burden. Molecular Neurodegeneration. 5(1). 45–45. 144 indexed citations

16.

Congdon, Erin E., Lili Wang, Edward S. Chang, et al.. (2009). Inhibition of Tau Polymerization with a Cyanine Dye in Two Distinct Model Systems. Journal of Biological Chemistry. 284(31). 20830–20839. 26 indexed citations

17.

Congdon, Erin E., et al.. (2008). Nucleation-dependent Tau Filament Formation. Journal of Biological Chemistry. 283(20). 13806–13816. 99 indexed citations

18.

Congdon, Erin E., et al.. (2007). Potency of a tau fibrillization inhibitor is influenced by its aggregation state. Archives of Biochemistry and Biophysics. 465(1). 127–135. 25 indexed citations

19.

Kuret, Jeff, et al.. (2005). Evaluating triggers and enhancers of tau fibrillization. Microscopy Research and Technique. 67(3-4). 141–155. 87 indexed citations

20.

Kuret, Jeff, Carmen N. Chirita, Erin E. Congdon, et al.. (2004). Pathways of tau fibrillization. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1739(2-3). 167–178. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact